Literature DB >> 6595055

Stage-related decrease in natural killer cell activity in untreated patients with mycosis fungoides.

S Levy, J L Tempé, P Caussade, A Aleksijevic, E Grosshans, S Mayer, J M Lang.   

Abstract

Natural killer activity of peripheral blood mononuclear cells against the human cell line K 562 was evaluated in 11 patients with mycosis fungoides and simultaneously in 10 age- and sex-matched controls. In the patient group, nine had no previous treatment and in two topical therapy had been discontinued more than 3 months before. None had any associated disease or concurrent therapy that could interfere with the immune system. Patients with early disease showed a mean specific lysis and a range of individual data similar to the controls whereas patients with advanced disease had a significant defect of natural killer activity at effector: target ratios of 100 : 1, 50 : 1, and 25 : 1, as shown by the Mann-Whitney test. Preincubation of effector cells with alpha-interferon for 1 h in a single patient with low natural killing capacity led to a clear increase of the specific lysis, suggesting reduced functional activity rather than depletion of effector cells.

Entities:  

Mesh:

Year:  1984        PMID: 6595055     DOI: 10.1007/bf00205749

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  8 in total

1.  Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas.

Authors:  P A Bunn; S I Lamberg
Journal:  Cancer Treat Rep       Date:  1979-04

2.  Initial event in mycosis fungoides of the skin is viral infection of epidermal Langerhans cells.

Authors:  R M MacKie
Journal:  Lancet       Date:  1981-08-08       Impact factor: 79.321

3.  Blood lymphocyte subpopulations in Mycosis fungoides and their functions in vitro.

Authors:  S Q Gu; B Petrini; L V von Stedingk; N Thyresson; J Wasserman
Journal:  Acta Derm Venereol       Date:  1981       Impact factor: 4.437

4.  Decreased natural-killer-cell activity in cutaneous T-cell lymphomas.

Authors:  L Laroche; D Kaiserlian
Journal:  N Engl J Med       Date:  1983-01-13       Impact factor: 91.245

5.  Natural cell-mediated cytotoxicity in cutaneous T-cell lymphomas.

Authors:  B A Neilan; E C Vonderheid; K J O'Neill
Journal:  J Invest Dermatol       Date:  1983-08       Impact factor: 8.551

6.  The immunological profile of mycosis fungoides.

Authors:  J R Jensen; K Thestrup-Pedersen; S Ahrons; H Zachariae
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

Review 7.  Natural killer cells: their roles in defenses against disease.

Authors:  R B Herberman; J R Ortaldo
Journal:  Science       Date:  1981-10-02       Impact factor: 47.728

8.  Depressed NK cell activity of peripheral blood mononuclear cells in untreated hodgkin's disease: enhancing effect of interferon in vitro.

Authors:  S Levy; J L Tempe; A Aleksijevic; C Giron; F Oberling; S Mayer; J M Lang
Journal:  Scand J Haematol       Date:  1984-10
  8 in total
  6 in total

1.  Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants.

Authors:  Barbara L Andersen; Lisa M Thornton; Charles L Shapiro; William B Farrar; Bethany L Mundy; Hae-Chung Yang; William E Carson
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

2.  Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma.

Authors:  M Di Renzo; P Rubegni; G De Aloe; L Paulesu; A L Pasqui; L Andreassi; A Auteri; M Fimiani
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

3.  Childhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer.

Authors:  Linda Witek Janusek; Dina Tell; Kevin Albuquerque; Herbert L Mathews
Journal:  Brain Behav Immun       Date:  2012-06-01       Impact factor: 7.217

4.  Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer.

Authors:  Linda Witek-Janusek; Kevin Albuquerque; Karen Rambo Chroniak; Christopher Chroniak; Ramon Durazo-Arvizu; Herbert L Mathews
Journal:  Brain Behav Immun       Date:  2008-03-21       Impact factor: 7.217

Review 5.  Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.

Authors:  William E Damsky; Jaehyuk Choi
Journal:  Curr Treat Options Oncol       Date:  2016-07

6.  Flow Cytometric Analysis of T, B, and NK Cells Antigens in Patients with Mycosis Fungoides.

Authors:  Serkan Yazıcı; Emel Bülbül Başkan; Ferah Budak; Barbaros Oral; Şaduman Balaban Adim; Zübeyde Ceylan Kalin; Güven Özkaya; Kenan Aydoğan; Hayriye Saricaoğlu; Şükran Tunali
Journal:  J Immunol Res       Date:  2015-12-16       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.